Lan Y. Huang

No. 1 Jianshe East Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression.

Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression.

Journal: Cancer biology & therapy
Published: January 29, 2026

TGF-β-activated NK-92 cell therapy for esophageal squamous cell carcinoma.

TGF-β-activated NK-92 cell therapy for esophageal squamous cell carcinoma.

Journal: International immunopharmacology
Published: April 17, 2025

The clathrin adaptor AP1-S1 is associated with immune infiltration and HLA loss, as a potential therapeutic target in lung adenocarcinoma.

The clathrin adaptor AP1-S1 is associated with immune infiltration and HLA loss, as a potential therapeutic target in lung adenocarcinoma.

Journal: International immunopharmacology
Published: November 14, 2024

Targeting YBX1-m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma.

Targeting YBX1-m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma.

Journal: Clinical and translational medicine
Published: September 11, 2024

Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII
Published: August 12, 2024

A Controllability Reinforcement Learning Method for Pancreatic Cancer Biomarker Identification.

A Controllability Reinforcement Learning Method for Pancreatic Cancer Biomarker Identification.

Journal: IEEE transactions on nanobioscience
Published: August 12, 2024

Human esophageal cancer stem-like cells escape the cytotoxicity of natural killer cells via down-regulation of ULBP-1.

Human esophageal cancer stem-like cells escape the cytotoxicity of natural killer cells via down-regulation of ULBP-1.

Journal: Journal of translational medicine
Published: February 01, 2024

Editorial: Emerging roles of circular RNAs in the tumor: functions and potential applications-volume II.

Editorial: Emerging roles of circular RNAs in the tumor: functions and potential applications-volume II.

Journal: Frontiers in cell and developmental biology
Published: November 15, 2023

SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.

SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.

Journal: International journal of oncology
Published: October 20, 2023

Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.

Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.

Journal: Oncotarget
Published: May 19, 2023

Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.

Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.

Journal: Molecular cancer
Published: August 17, 2022

Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma.

Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma.

Journal: Journal of advanced research
Published: July 25, 2022
Showing 1-12 of 77

Last Updated: 09/26/2026